Free Trial
NASDAQ:PTIX

Atrinsic (PTIX) Stock Price, News & Analysis

Atrinsic logo
$0.46 0.00 (0.00%)
As of 11/13/2026 03:47 PM Eastern

About Atrinsic Stock (NASDAQ:PTIX)

Advanced

Key Stats

Today's Range
$0.46
▼
$0.47
50-Day Range
$0.46
▼
$1.06
52-Week Range
$0.13
▼
$2.38
Volume
831 shs
Average Volume
24,887 shs
Market Capitalization
$832.60 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Atrinsic, Inc. was an online marketing and digital media company that developed and operated consumer-focused websites and provided performance-based marketing services. Its activities included customer acquisition, lead generation, online advertising and related digital commerce initiatives.

The company’s operations were primarily conducted through internet-based channels and were aimed at connecting consumers with products and services offered by third parties. Publicly available information about Atrinsic’s specific brands, geographic markets and management team is limited.

Atrinsic later changed its corporate direction and became Protagenic Therapeutics, Inc., a biotechnology company focused on developing therapeutics based on neuropeptides. As a result, the company associated with the PTIX symbol is generally identified with Protagenic Therapeutics rather than its former Atrinsic online-marketing business.

AI Generated. May Contain Errors.

Receive PTIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrinsic and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PTIX Stock News Headlines

Atrinsic (NASDAQ:PTIX) Stock Falls 14.3% - Here's Why
$0. Later: $29.97.
Bill Poulos is giving away his Simple Options Trading For Beginners book through a temporary link. Once that link expires, it returns to its usual price of $29.97. The content stays the same - plain-English lessons and a handful of proven techniques - only the price changes. Waiting means paying for something you could have gotten for free.tc pixel
Protagenic Therapeutics, Inc. (PTIX) - Yahoo Finance
Protagenic Therapeutics swaps warrants for shares
See More Headlines

PTIX Stock Analysis - Frequently Asked Questions

Atrinsic's stock was trading at $1.30 at the beginning of the year. Since then, PTIX shares have decreased by 64.6% and is now trading at $0.46.

Atrinsic Inc. (NASDAQ:PTIX) posted its quarterly earnings results on Wednesday, September, 10th. The company reported ($1.37) earnings per share for the quarter.

Shares of Atrinsic reverse split on Monday, May 5th 2025.A 1-14 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, May 4th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of PTIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Atrinsic investors own include Aptorum Group (APM), Plug Power (PLUG), Boeing (BA), Bank of America (BAC), Astrotech (ASTC), Athersys (ATHX) and American Airlines Group (AAL).

Company Calendar

Today
11/15/2026
Next Earnings (Estimated)
11/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:PTIX
CIK
1022899
Employees
2
Year Founded
1994

Profitability

EPS (Trailing Twelve Months)
$2.33
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.53 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-379.72%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.29
Quick Ratio
0.29

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.96 per share
Price / Book
0.23

Miscellaneous

Outstanding Shares
1,810,000
Free Float
1,780,000
Market Cap
$832.60 thousand
Optionable
Not Optionable
Beta
1.94

Social Links

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:PTIX) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners